Pharmacovigilance Case Processing

Pharmacovigilance Case Processing is a systematic method within safety data management that involves the identification, validation, evaluation, and regulatory reporting of individual adverse event cases from various sources to ensure timely detection and assessment of potential drug safety signals.

6

Publications

218

Citations

42

Authors

19

Institutions

Publications per year

2017–2026

5

Variants

Pharmacovigilance Case Management

Authors

42

  1. SS
    Sundeep Sethi

    Eli Lilly (United States), United States

    1 publications · 48 citations

    1

    h-index

  2. CM
    Chris M. Davis

    La Roche College, United States

    1 publications · 48 citations

    1

    h-index

  3. SB
    Sheryl Beauchamp

    Bristol-Myers Squibb (Switzerland), Switzerland

    1 publications · 32 citations

    1

    h-index

  4. KK
    Krishan Kumar

    Eternal University, India

    1 publications · 86 citations

    1

    h-index

  5. CM
    Christoph Meier

    Boston Collaborative Drug Surveillance Program, United States

    1 publications · 19 citations

    1

    h-index

1–5 of 42

Venues

  1. Pharmaceutical Medicine

    2 publications · 80 citations

    2

    h-index

  2. Clinical Pharmacology & Therapeutics

    CPT · 1 publications · 86 citations

    1

    h-index

  3. Drug Safety

    1 publications · 19 citations

    1

    h-index

  4. European Journal of Clinical Pharmacology

    1 publications · 21 citations

    1

    h-index

  5. Perspectives in Clinical Research

    1 publications · 12 citations

    1

    h-index

1–5